Literature DB >> 20442731

Cancer: What is the best screening test for colorectal cancer?

Jean Faivre.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20442731     DOI： 10.1038/nrgastro.2010.49

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II.

Authors:  M Rasmussen; C Fenger; O Kronborg
Journal:  Scand J Gastroenterol       Date:  2003-01       Impact factor: 2.423

Review 2.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.

Authors:  Vincent Dancourt; Catherine Lejeune; Côme Lepage; Marie Claude Gailliard; Bernard Meny; Jean Faivre
Journal:  Eur J Cancer       Date:  2008-08-27       Impact factor: 9.162

4.  Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.

Authors:  L Guittet; V Bouvier; N Mariotte; J P Vallee; D Arsène; S Boutreux; J Tichet; G Launoy
Journal:  Gut       Date:  2006-08-04       Impact factor: 23.059

5.  Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.

Authors:  Alex Vilkin; Paul Rozen; Zohar Levi; Amal Waked; Eran Maoz; Shlomo Birkenfeld; Yaron Niv
Journal:  Am J Gastroenterol       Date:  2005-11       Impact factor: 10.864

6.  Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).

Authors:  B Denis; I Gendre; F Aman; F Ribstein; P Maurin; P Perrin
Journal:  Eur J Cancer       Date:  2009-08-06       Impact factor: 9.162

7.  Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.

Authors:  Nereo Segnan; Carlo Senore; Bruno Andreoni; Alberto Azzoni; Luigi Bisanti; Alessandro Cardelli; Guido Castiglione; Cristiano Crosta; Andrea Ederle; Alberto Fantin; Arnaldo Ferrari; Mario Fracchia; Franco Ferrero; Stefano Gasperoni; Serafino Recchia; Mauro Risio; Tiziana Rubeca; Giorgio Saracco; Marco Zappa
Journal:  Gastroenterology       Date:  2007-03-21       Impact factor: 22.682

8.  Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Authors:  James E Allison; Lori C Sakoda; Theodore R Levin; Jo P Tucker; Irene S Tekawa; Thomas Cuff; Mary Pat Pauly; Lyle Shlager; Albert M Palitz; Wei K Zhao; J Sanford Schwartz; David F Ransohoff; Joseph V Selby
Journal:  J Natl Cancer Inst       Date:  2007-09-25       Impact factor: 13.506

9.  Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

Authors:  Leo G van Rossum; Anne F van Rijn; Robert J Laheij; Martijn G van Oijen; Paul Fockens; Han H van Krieken; Andre L Verbeek; Jan B Jansen; Evelien Dekker
Journal:  Gastroenterology       Date:  2008-03-25       Impact factor: 22.682

10.  Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.

Authors:  L Hol; M E van Leerdam; M van Ballegooijen; A J van Vuuren; H van Dekken; J C I Y Reijerink; A C M van der Togt; J D F Habbema; E J Kuipers
Journal:  Gut       Date:  2010-01       Impact factor: 23.059
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.